BioNano Genomics, Inc Uncategorized Contracts & Agreements
17 Contracts & Agreements
- Option and Sublicense Agreement by and between the Registrant and Pacific Biosciences of California, Inc. dated February 2, 2016 (Filed With SEC on August 7, 2024)
- Fourth Amendment (Filed With SEC on August 7, 2024)
- Description of the Companys Securities (Filed With SEC on March 5, 2024)
- Letter Agreement between the Company and the Purchaser, dated February 27, 2024 (Filed With SEC on February 28, 2024)
- Description of the Companys Securities (Filed With SEC on March 9, 2023)
- Bionano Genomics, Inc. 2020 Inducement Plan dated August 20, 2020, as amended (Filed With SEC on October 12, 2021)
- Description of the Companys Securities (Filed With SEC on March 23, 2021)
- Bionano Genomics, Inc. 2020 Inducement Plan (Filed With SEC on August 24, 2020)
- Description of the Company's Securities (Filed With SEC on August 13, 2020)
- Description of the Companys Securities (Filed With SEC on March 10, 2020)
- Form of Warrants Amendment and Agreement (Filed With SEC on March 2, 2020)
- Amendment Agreement, dated November 19, 2018, by and between the Company and Western Alliance Bank, an Arizona corporation (Filed With SEC on November 21, 2018)
- Form of Unit Certificate (Filed With SEC on August 15, 2018)
- Amendment to Patent Sublicense Agreement by and between the Registrant and Industry 3200, dated June 28, 2018 (Filed With SEC on July 13, 2018)
- Option and Sublicense Agreement by and between the Registrant and Pacific Biosciences of California, Inc. dated February 2, 2016 (Filed With SEC on June 28, 2018)
- Sublicense Agreement by and between the Registrant and Industry 3200 dated December 27, 2013 (Filed With SEC on June 28, 2018)
- Agreement by and between the Registrant and Berry Genomics Co., Ltd. dated August 2, 2016 (Filed With SEC on June 28, 2018)
